McKinsey’s “State of Organizations 2026” report highlights several disruptions affecting organizations globally, including challenges hospital and health system leaders are grappling with. The report is based on survey responses collected from June to September from more than 10,000 senior executives…
The Latest
A disability advocacy organization and two individuals have filed a class-action lawsuit against Epic, alleging the EHR vendor uses its dominant market position to block interoperability and make it difficult for patients to access their medical records. The lawsuit, filed…
Saginaw, Mich.-based Covenant HealthCare and Detroit-based Henry Ford Health have launched a clinical affiliation to expand access to complex neurological care in Saginaw, effective April 1. The partnership will create a joint program, Covenant HealthCare in partnership with Henry Ford…
Private equity firms have become a major force in healthcare, investing more than $1 trillion over the last ten years, according to a recent report from New York University’s Stern Center for Business and Human Rights. The report, published March…
Less than one year after unionizing, nurses and advanced practitioners at UPMC Magee-Womens Hospital in Pittsburgh are proposing national nurse staffing standards as part of their first contract negotiations with UPMC. SEIU Healthcare Pennsylvania members presented the proposals to Pittsburgh-based…
Idaho Republican state lawmakers have introduced a bill to repeal Medicaid expansion, the Idaho Capital Sun reported March 9. Four things to know: 1. The proposed legislation would repeal Medicaid expansion on Jan. 1, 2028, removing about 90,000 Idaho residents…
Ipsen, a Paris-based drugmaker, is removing its cancer drug Tazverik (tazemetostat) from the U.S. market because of safety concerns. An ongoing Tazverik clinical trial has reported adverse events of secondary hematologic malignancies — which are blood cancers — indicating “the…
The Government Accountability Office is calling on HHS to increase transparency in how it assesses and mitigates risk related to high-risk pathogen research. In a report released Feb. 19, the GAO said HHS does not consistently disclose key details about…
Anthem Blue Cross of California is bringing its controversial out-of-network penalty policy to California on June 1, a move that has already drawn legislative backlash in the insurer’s home state of Indiana. Under the policy, participating hospitals and facilities in…
A March 9 draft guidance from the FDA proposes an allowance for biosimilar sponsors to use clinical data from outside the U.S. to seek the agency’s approval, which would reduce the requirement of at least one study in the approval…